The development of bacterial translocation and endotoxemia from an impaired intestinal barrier lead to hepatic inflammation and injury, likely through the activation of toll-like receptor-4 (TLR4) [4]. The gene discussed is TLR4; the disease is serum lipopolysaccharide activity.